Four biotech stocks surging on optimism about drug trials, product launches

bluebird bio Employees of bluebird bio, which announced the publication of a case study on the first patient with severe sickle cell disease treated with its gene-therapy product. Biotechnology stocks are running higher on positive results from drug trials. Approvals Read more ...

The post Four biotech stocks surging on optimism about drug trials, product launches appeared first on Biggies Boxers.

source http://www.biggiesboxers.com/four-biotech-stocks-surging-on-optimism-about-drug-trials-product-launches/